Abstract: . . .  have the right expertise when the new work begins.   Dr. Schechtman then reviewed the meeting objectives (listed above) and noted the Secretary’s desire that the work on the paper be substantially completed by the end of this meeting.  Dr. Schechtman emphasized again the value a Federal advisory committee provides when, despite diverse points of view, it presents a picture of where consensus exists.  He acknowledged that for some topics, the Committee will only achieve consensus with a “some members believe A, some members believe B” format.  He encouraged the Committee to . . .
. . .  In addition to the new draft, suggestions will be made for how best to advance additional sections of the report and/or possible titles for the report, including scheduling conference calls and/or requesting and compiling additional comments.  Summary Dr. Layton thanked Committee members for their work during the meeting and adjourned the meeting at 4:00 p.m.  . . .
. . .  labeling of products of modern biotechnology is the middle ground: allowing such products to come to market but making it possible for consumers to avoid products they oppose. Other AC21 members believe consumer interest is not focused on whether food products are derived through agricultural biotechnology or contain genetically engineered ingredients. They assert that those consumers who do have an interest in whether products are developed from genetic engineering, have multiple means of finding this information, including the Internet, calling the company and other avenues.  . . .
. . .  be made for how best to advance additional sections of the report and/or possible titles for the report, including scheduling conference calls and/or requesting and compiling additional comments.  Summary Dr. Layton thanked Committee members for their work during the meeting and adjourned the meeting at 4:00 p.m.  . . .
. . .  January 5-6, 2006 Room 107A, USDA Jamie L. Whitten Building Washington, D.C. Draft Meeting Summary   On January 5-6, 2006, the United States Department of Agriculture (USDA) convened the eleventh plenary meeting of the Advisory Committee on Biotechnology and 21 st Century Agriculture (AC21). The meeting objectives were: To complete major work on a paper examining the impacts of agricultural biotechnology on American agriculture and USDA over the next five-to-ten years, including determination of specific steps and timeframe for completion and submission . . .
--3000,5,300,2904,35788